MedTrace Logo

APERTO CVS PMCF Study

NCT04514406 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2024-02-07

No results posted yet for this study

Summary

Prospective Observational Single Arm study aimed to assess safety and effectiveness of APERTO OTW DCB in treating stenosis and restenosis of central veins in dialysis patients

Conditions

  • Dialysis; Complications
  • Central Vein Obstruction
  • Stenosis
  • Restenosis

Interventions

DEVICE

APERTO OTW DCB

Drug Coated Balloon Angioplasty

Sponsors & Collaborators

  • CliPS Service

    collaborator UNKNOWN

  • OPIS srl

    collaborator UNKNOWN

  • Cardionovum GmbH

    lead INDUSTRY

Principal Investigators

  • Petra Michel, MD · Klinikum Hochsauerland

  • Michael Lichtenberg, MD, FESC · Klinikum Hochsauerland

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-25
Primary Completion
2023-12-01
Completion
2023-12-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04514406 on ClinicalTrials.gov